Komatsushima, Japan

Shinichi Ishikawa

This inventor holds 10 USPTO granted patents and 1 EPO patent. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 1996-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shinichi Ishikawa. Retrieved from https://idiyas.com/inventor/shinichi-ishikawa-3rn1amlp

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 60.0

 

Average Co-Inventor Count = 3.3

ph-index = 4

Forward Citations = 123(Granted Patents)


Location History:

  • Tokushima, JP (1996)
  • Itano-gun, JP (1997)
  • Osaka, JP (2014)
  • Komatsushima, JP (2015 - 2017)

Company Filing History:


Years Active: 1996-2017

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Innovations of Shinichi Ishikawa: A Pioneer in Ophthalmic Solutions

Introduction: Shinichi Ishikawa, an accomplished inventor based in Komatsushima, Japan, has made significant contributions to the field of ophthalmology. With a robust portfolio of ten patents, his work has focused on developing innovative solutions for eye care, addressing the pressing needs of patients suffering from dry eye syndrome.

Latest Patents: One of Shinichi Ishikawa's noteworthy inventions is the aqueous ophthalmic suspension of crystalline rebamipide. This invention offers an ophthalmic product that contains rebamipide, renowned for its ability to maintain transparency and provide a pleasant user experience. The suspension boasts a neutral to weakly acidic pH that ensures it is gentle on the keratoconjunctiva, thus minimizing the risk of injury for patients. The innovative preparation process involves the mixture of an aqueous solution of rebamipide, enhanced with a base like sodium hydroxide, and combined with an aqueous acidic solution, such as hydrochloric acid, that incorporates water-soluble polymers and surfactants to achieve optimal transparency.

Career Highlights: Shinichi Ishikawa is associated with Otsuka Pharmaceutical Company, Limited, where he has been instrumental in advancing eye care technologies. His inventive spirit has helped pioneer new methodologies and products that significantly enhance patient comfort and treatment effectiveness.

Collaborations: Throughout his career, Shinichi has enjoyed the opportunity to collaborate with talented coworkers, including Shunichiro Sumida and Shinji Nishitani. These collaborations have fostered a creative environment that has allowed for the exchange of ideas and the development of innovative products aimed at improving patient outcomes.

Conclusion: With ten patents to his name and a focus on improving the well-being of individuals suffering from dry eye syndrome, Shinichi Ishikawa exemplifies the significance of innovation within the pharmaceutical industry. His dedication to enhancing ophthalmic products highlights the role of inventors in creating solutions that address real-world medical challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…